Khalil Muhammad Abdul Mabood, Tan Jackson, Khan Taqi F Toufeeq, Khalil Muhammad Ashhad Ullah, Azmat Rabeea
Diaverum Prince Abdul Majeed Renal Centre, Al Imam Ahmad ibn Hanbal, Jeddah 21146, Saudi Arabia.
RIPAS Hospital, Bandar Seri Begawan BA1710, Brunei Darussalam.
Int Sch Res Notices. 2017 Jul 2;2017:2693681. doi: 10.1155/2017/2693681. eCollection 2017.
Kidney transplantation (KT) is one of the treatment options for patients with chronic kidney disease. The number of patients waiting for kidney transplantation is growing day by day. Various strategies have been put in place to expand the donor pool. Extended criteria donors are now accepted more frequently. Increasing number of elderly donors with age > 60 years, history of diabetes or hypertension, and clinical proteinuria are accepted as donor. Dual kidney transplantation (DKT) is also more frequently done and experience with this technique is slowly building up. DKT not only helps to reduce the number of patients on waiting list but also limits unnecessary discard of viable organs. Surgical complications of DKT are comparable to single kidney transplantation (SKT). Patient and graft survivals are also promising. This review article provides a summary of evidence available in the literature.
肾移植(KT)是慢性肾病患者的治疗选择之一。等待肾移植的患者数量与日俱增。已采取各种策略来扩大供体库。如今,扩大标准供体被更频繁地接受。年龄>60岁、有糖尿病或高血压病史以及临床蛋白尿的老年供体作为供体被接受的数量在增加。双肾移植(DKT)也更频繁地进行,并且这项技术的经验正在慢慢积累。DKT不仅有助于减少等待名单上的患者数量,还能限制对 viable 器官的不必要丢弃。DKT的手术并发症与单肾移植(SKT)相当。患者和移植物的存活率也很可观。这篇综述文章总结了文献中可用的证据。